Peptide-related research · identity and formulation matter
What is TB-500?
TB-500 is a name used for products associated with thymosin beta-4 research. The exact sequence and chemical identity matter: a fragment and full-length thymosin beta-4 are not interchangeable just because a seller uses similar terminology.
How does TB-500 work?
Thymosin beta-4 binds actin, a protein involved in the internal framework of cells. Actin organisation is relevant to cell shape and movement, which helps explain scientific interest in tissue-repair processes. [1]
What does the research show?
Primary biochemical research identified thymosin beta-4 as an actin-binding protein. A separate 1999 study investigated wound healing with thymosin beta-4. These papers explain the biological research background; they do not validate every substance marketed as TB-500. [1]
What the evidence does not establish
Read the methods to identify the sequence, preparation, route and experimental model. Findings about full-length thymosin beta-4 cannot simply be treated as clinical proof for a fragment or a differently characterised vial.
Safety questions to discuss
Before relying on an advertised healing claim, ask whether the cited study tested the actual substance on the label and whether it measured outcomes in people. [2]
Frequently asked questions
Is TB-500 automatically identical to thymosin beta-4?
No. Confirm the chemical identity and sequence used in both the product and the study.
Does actin research establish a human recovery benefit?
No. Explaining a cellular process is different from demonstrating clinical effectiveness.
Sources and further reading
- Thymosin beta 10 and thymosin beta 4 as actin monomer sequestering proteins — primary research
- Thymosin beta4 accelerates wound healing — experimental study, 1999
These are selected sources, not a systematic review. Check publication dates, study methods and the exact substance tested. Artwork does not establish clinical benefit.